Corza Medical Distribution GmbH, Austria BranchSeptember 12, 2025

FDA 483 - Corza Medical Distribution GmbH, Austria Branch - September 12, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Corza Medical Distribution GmbH, Austria Branch

Record Details

Corza Medical Distribution GmbH, Austria Branch, a licensed combination product manufacturer in Linz, Austria, received an FDA Form 483 citing significant quality control and procedural deficiencies. Observations included the use of expired reagent standard curves for TachoSil product release and deficient investigations. The firm also failed to timely initiate deviations, close Out of Specification investigations, and adequately document sanitation practices in manufacturing areas.

Company: Corza Medical Distribution GmbH, Austria Branch
Inspection Date: September 12, 2025
Product Type: Biologics
Office: Office of Inspections and Investigations
People: Priscilla M. Pastrana (investigator)
Richard L. Bartlett

Open in Dashboard

ID · c99c08ce-3aa6-47a1-a9cd-f99ac1336542